-
Mashup Score: 9What are Cancer Disparities and How Are Dana-Farber Researchers Addressing Them? | Dana-Farber - 5 month(s) ago
Cancer disproportionately affects many underserved groups, including Black Americans and those of low socioeconomic status.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 12What Cancers Can Immunotherapy Treat? | Dana-Farber - 5 month(s) ago
Immunotherapy for cancer is a form of treatment that uses the body’s immune system to combat cancer. It is being applied to a wide range of cancers.
Source: blog.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
Immunotherapy is changing the game in cancer treatment. Learn the latest on which types of cancer can now be treated with immunotherapy. https://t.co/ltBj2qHE1S #CancerCare #Immunotherapy #CancerTreatment #Immunotherapy #CheckpointInhibitors https://t.co/S7YSYdzhO3
-
-
Mashup Score: 11Multiple Myeloma Survivor Writes New Chapter for All | Dana-Farber Cancer Institute - 5 month(s) ago
Multiple myeloma survivor turns her diagnosis into a mission, driving progress in research and offering hope to others facing the disease.
Source: blog.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
.@KathyGiusti’s diagnosis of multiple myeloma sparked a new mission - She co-founded the Multiple Myeloma Research Foundation (MMRF) with her twin sister, helping thousands access cutting-edge treatments and advancing numerous FDA-approved drugs. https://t.co/SpIrVf6pyD https://t.co/atuyyonQj6
-
-
Mashup Score: 8Metastatic Breast Cancer Survivor Proves Her Endurance at NYC Marathon | Dana-Farber Cancer Institute - 6 month(s) ago
When Meghan MacDonald’s cancer was found to be ER+ and HER2-negative, treatment began with an aromatase inhibitor and CDK 4/6 inhibitor.
Source: blog.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
In early 2023, a biopsy confirmed runner Meghan MacDonald had late-stage metastatic breast cancer. Under the care of Dana-Farber Brigham Cancer Center – Foxborough, Meghan was able to face her diagnosis with courage. Learn more about Meghan’s journey: https://t.co/SscuIbjg07 https://t.co/d756l3a0h0
-
-
Mashup Score: 11Living with Multiple Myeloma, Doctor Becomes Powerful Resource and Patient Advocate | Dana-Farber Cancer Institute - 6 month(s) ago
After his multiple myeloma diagnosis, Jim Omel, MD became a leading advocate, supporting cancer patients and research worldwide.
Source: blog.dana-farber.orgCategories: General Medicine News, Hem/OncsTweet-
RT @IMFjimMYELOMA: Living with Multiple Myeloma, Doctor Becomes Powerful Resource and Patient Advocate - https://t.co/vATLhGDUij #GoogleAle…
-
-
Mashup Score: 11Living with Multiple Myeloma, Doctor Becomes Powerful Resource and Patient Advocate | Dana-Farber Cancer Institute - 6 month(s) ago
After his multiple myeloma diagnosis, Jim Omel, MD became a leading advocate, supporting cancer patients and research worldwide.
Source: blog.dana-farber.orgCategories: General Medicine News, Hem/OncsTweet-
RT @IMFjimMYELOMA: Living with Multiple Myeloma, Doctor Becomes Powerful Resource and Patient Advocate - https://t.co/vATLhGDUij #GoogleAle…
-
-
Mashup Score: 2Immune Checkpoint Inhibitors Show Effectiveness in Metastatic Colorectal Cancer | Dana-Farber Cancer Institute - 6 month(s) ago
A combination of checkpoint inhibitors shows promising results in treating metastatic colorectal cancer, marking a potential breakthrough.
Source: blog.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
A promising combination of checkpoint inhibitors is showing effectiveness in treating chemotherapy-resistant metastatic #colorectalcancer. This development could redefine treatment options for patients. Learn more: https://t.co/2q4jTziaec
-
-
Mashup Score: 4Study Uncovers Potential Targeted Therapy for Small Cell Lung Cancer | Dana-Farber Cancer Institute - 6 month(s) ago
Dana-Farber researchers discover a potential targeted therapy for small cell lung cancer, showing promise for treatment-resistant patients.
Source: blog.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
New research reveals a potential targeted therapy for small cell #lung cancer, focusing on the SWI/SNF complex. This could offer new hope for POU2F3-positive patients with limited treatment options. Learn more: https://t.co/hjAU3B09lh
-
-
Mashup Score: 5Breast Cancer Disparities: What Is Dana-Farber Doing to Address Them? | Dana-Farber Cancer Institute - 6 month(s) ago
Breast cancer disparities: Addressing the root causes of disparities to close the gap in screening, access to care, and breast cancer diagnosis.
Source: blog.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
Facing a cancer diagnosis can be overwhelming. Dana-Farber's Breast Oncology Program has a dedicated patient navigator who helps lower barriers patients face when trying to access breast cancer care. Learn more: https://t.co/3kCUhQ1LDb https://t.co/sNI5vRocfA
-
-
Mashup Score: 20Researchers Uncover Key Actor Behind Breast Cancer Brain Metastasis | Dana-Farber Cancer Institute - 6 month(s) ago
Dana-Farber researchers have identified a critical mechanism driving breast cancer metastasis to the brain, revealing potential targets for new treatments.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
Researchers at Dana-Farber have uncovered a key mechanism driving breast cancer's spread to the brain. This breakthrough opens the door to potential new treatments targeting the KDM6A protein to prevent brain metastasis. https://t.co/Cv875YREzC https://t.co/nRTAH62Ba5
-
Cancer disproportionately affects many underserved groups. Dana-Farber investigators have undertaken a range of studies to understand the causes of these inequalities and develop approaches to alleviating them. https://t.co/JBgDr4jvw8 https://t.co/pkjanOTySb